Intravitreal pegaptanib for the treatment of ischemic diabetic macular edema

PURPOSE: Pegaptanib has been shown to be effective in treating diabetic macular edema (DME). In the original Phase II/III trial, however, patients with macular ischemia were excluded. In this study, we treated patients with ischemic DME. METHODS: Macular ischemia was defined as a 30% increase in the...

Descripción completa

Detalles Bibliográficos
Autores principales: Kiire, Christine A, Morjaria, Rupal, Rudenko, Anna, Fantato, Alexina, Smith, Lewis, Smith, Amy, Chong, Victor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4686329/
https://www.ncbi.nlm.nih.gov/pubmed/26715833
http://dx.doi.org/10.2147/OPTH.S90322

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4686329/
https://www.ncbi.nlm.nih.gov/pubmed/26715833
http://dx.doi.org/10.2147/OPTH.S90322

Ejemplares similares